Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 21;82(8):1421–1426. doi: 10.1054/bjoc.1999.1128

A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears

M V Jacobs 1, D Zielinski 1, C J L M Meijer 1, R P Pol 1, F J Voorhorst 2, F A de Schipper 3, A P Runsink 4, P J F Snijders 1, J M M Walboomers 1,1
PMCID: PMC2363381  PMID: 10780521

Abstract

The efficacy of four methods to recover DNA from Papanicolaou (Pap)-stained archival cervical smears for optimal detection of human papillomavirus (HPV) DNA by GP5+/bioGP6+ polymerase chain reaction (PCR) was investigated. Two of the methods were based on proteinase K treatment and two based on treatment with guanidinium thiocyanate (GTC). The quality of the DNA as measured by PCR assays amplifying different sizes of the β-globin gene appeared to be superior for the GTC-based assays. Using competitive β-globin PCR assays, one of the GTC-based, assays, provisionally named High Pure PCR Template Preparation (HPPTP) assay, yielded by far the highest quantity of amplifiable DNA. It allowed the recovery of 2.2 × 105to 3 × 105genome equivalents in smears containing 5 × 105to 20 × 105nucleated cells, indicating a mean efficiency of 26% (range of 15–44%). In contrast, the other methods revealed markedly lower efficiencies varying from 1% to 10%. The use of the HPPTP assay as a reliable processing procedure was validated by demonstrating a complete agreement in HPV detection and 93% agreement in HPV typing between 39 archival Pap-stained and paired fresh-frozen cervical smears. This method was applied to 40 archival smears from ten cervical cancer patients (selected from a group of 200 patients) which had a history of 3–6 smears with the first smear being Pap 1 or 2 taken at least 5 years before cancer was diagnosed. The average time period between the first Pap 1/2 smear that contained the same HPV type as in the corresponding carcinoma and diagnosis of cervical cancer was 12.0 ± 2.9 years. All subsequent smears were invariably positive for the same HPV type which was also found in the cervical cancer biopsy. In conclusion, the HPPTP assay provides a reliable and efficient means to extract DNA from Pap-stained archival cervical smears for the detection of HPV DNA by PCR and would be the method of choice for future HPV analysis of archival Pap-stained cervical smears. © 2000 Cancer Research Campaign

Keywords: HPV, PCR, archival Pap smears

Full Text

The Full Text of this article is available as a PDF (97.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ho G. Y., Burk R. D., Klein S., Kadish A. S., Chang C. J., Palan P., Basu J., Tachezy R., Lewis R., Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995 Sep 20;87(18):1365–1371. doi: 10.1093/jnci/87.18.1365. [DOI] [PubMed] [Google Scholar]
  2. Jacobs M. V., Snijders P. J., van den Brule A. J., Helmerhorst T. J., Meijer C. J., Walboomers J. M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997 Mar;35(3):791–795. doi: 10.1128/jcm.35.3.791-795.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jacobs M. V., Walboomers J. M., van Beek J., Voorhorst F. J., Verheijen R. H., Meijer C. J., van den Brule A. J., Helmerhorst T. J., Snijders P. J. A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings. Br J Cancer. 1999 Sep;81(1):114–121. doi: 10.1038/sj.bjc.6690659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Koss L. G. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989 Feb 3;261(5):737–743. [PubMed] [Google Scholar]
  5. Meijer C. J., Helmerhorst T. J., Rozendaal L., van der Linden J. C., Voorhorst F. J., Walboomers J. M. HPV typing and testing in gynaecological pathology: has the time come? Histopathology. 1998 Jul;33(1):83–86. doi: 10.1046/j.1365-2559.1998.00436.x. [DOI] [PubMed] [Google Scholar]
  6. Nobbenhuis M. A., Walboomers J. M., Helmerhorst T. J., Rozendaal L., Remmink A. J., Risse E. K., van der Linden H. C., Voorhorst F. J., Kenemans P., Meijer C. J. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999 Jul 3;354(9172):20–25. doi: 10.1016/S0140-6736(98)12490-X. [DOI] [PubMed] [Google Scholar]
  7. Poljak M., Barlic J., Seme K., Avsic-Zupanc T., Zore A. Isolation of DNA from archival Papanicolaou stained cytological smears using a simple salting-out procedure. Clin Mol Pathol. 1995 Feb;48(1):M55–M56. doi: 10.1136/mp.48.1.m55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Puranen M., Saarikoski S., Syrjänen K., Syrjänen S. Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears. Acta Cytol. 1996 May-Jun;40(3):391–395. doi: 10.1159/000333842. [DOI] [PubMed] [Google Scholar]
  9. Remmink A. J., Walboomers J. M., Helmerhorst T. J., Voorhorst F. J., Rozendaal L., Risse E. K., Meijer C. J., Kenemans P. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer. 1995 May 4;61(3):306–311. doi: 10.1002/ijc.2910610305. [DOI] [PubMed] [Google Scholar]
  10. Sepp R., Szabó I., Uda H., Sakamoto H. Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol. 1994 Apr;47(4):318–323. doi: 10.1136/jcp.47.4.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  12. de Roda Husman A. M., Snijders P. J., Stel H. V., van den Brule A. J., Meijer C. J., Walboomers J. M. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer. 1995 Aug;72(2):412–417. doi: 10.1038/bjc.1995.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. van Oortmarssen G. J., Habbema J. D., van Ballegooijen M. Predicting mortality from cervical cancer after negative smear test results. BMJ. 1992 Aug 22;305(6851):449–451. doi: 10.1136/bmj.305.6851.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol. 1994;186:131–156. doi: 10.1007/978-3-642-78487-3_8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES